APOGEE BIOTECHNOLOGY CORPORATION
HUMMELSTOWN, United States · Founded 2015 · $525K raised
- Headquarters
- HUMMELSTOWN, Pennsylvania
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2G
- Website
- apogee-biotech.com
- Total Funding
- $525K
- Last Round
- $225K GrantJan 2017
- Rounds
- 2
About
Apogee Biotechnology Corporation develops orally available small molecule inhibitors of sphingosine kinase for the treatment of solid tumors and chronic inflammatory diseases. The company's lead compound ABC294640 (opaganib) has demonstrated efficacy in preclinical models of renal, breast, pancreatic, brain, and colon cancers, as well as inflammatory conditions including arthritis, IBD, and COVID-19.
Summary
APOGEE BIOTECHNOLOGY CORPORATION is a Biotech company based in HUMMELSTOWN, United States, founded in 2015. It has raised $525K in total across 2 rounds, most recently a $225K Grant round in Jan 2017. Investors include National Cancer Institute and National Institute of Allergy and Infectious Diseases.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2017
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...